This is an advanced, rapid molecular test used to detect tuberculosis (TB) or other similar infections directly from a small piece of body tissue (obtained via a biopsy or minor surgical procedure).

It uses a technology called CBNAAT (Cartridge-Based Nucleic Acid Amplification Test), famously known as the GeneXpert test. Instead of waiting weeks to grow bacteria in a lab, this machine looks directly for the genetic material (DNA) of the bacteria, giving highly accurate results in just a few hours.

When is a tissue sample used?
While TB is most common in the lungs, it can also infect other parts of the body—this is known as Extrapulmonary TB. Doctors recommend this test on tissue samples when they suspect TB in areas like:

Lymph nodes (swellings in the neck, armpits, etc.)

Skin or bone tissue

Gastrointestinal tissue

Other internal organs

What does the test detect?
The test checks for three crucial things simultaneously:

M.Tb (Mycobacterium tuberculosis): The specific bacteria that causes traditional Tuberculosis.

NTM (Nontuberculous Mycobacteria): A different family of environmental bacteria. NTM can cause tissue infections that look exactly like TB but require completely different antibiotics to cure.

Rifampicin Resistance: It instantly checks if the bacteria are resistant to Rifampicin (a major first-line TB medicine). This tells your doctor immediately if a standard treatment will work or if a specialized, stronger regimen is required.

This is a modern, rapid molecular test used to detect tuberculosis (TB) from a cough sample (sputum). It uses an advanced technology called CBNAAT (Cartridge-Based Nucleic Acid Amplification Test), commonly known as the GeneXpert test.

Instead of just looking for the bacteria under a microscope, this test looks directly for the DNA of the bacteria, making it incredibly fast and accurate.

What does the test detect?
The test checks for three major things at the same time:

M.Tb (Mycobacterium tuberculosis): The bacteria responsible for causing active Tuberculosis.

NTM (Nontuberculous Mycobacteria): A different family of environmental bacteria that can mimic TB symptoms but requires completely different treatment.

Rifampicin Resistance: It checks if the TB bacteria are resistant to Rifampicin, one of the main medicines used to cure TB. This helps doctors know immediately if a stronger treatment plan is needed.

Why is this test preferred over routine tests?
Speed: Gives accurate results within a few hours, whereas traditional bacterial cultures can take weeks.

High Accuracy: It can find TB bacteria even if there is only a tiny amount present in the sputum sample (which routine microscopy often misses).

Clear Distinction: It tells the doctor exactly whether you have standard TB or an NTM infection, preventing the wrong medicine from being prescribed.

Test Overview: CBNAAT for M.Tb/NTM Detection (Pleural Fluid)
This test utilizes Cartridge-Based Nucleic Acid Amplification Test (CBNAAT)—commonly known as the GeneXpert assay—to rapidly detect the presence of Mycobacterium tuberculosis (M.Tb) complex DNA in pleural fluid samples. Additionally, it differentiates M.Tb from Nontuberculous Mycobacteria (NTM) and simultaneously detects mutations associated with resistance to Rifampicin, a primary first-line anti-tubercular drug.

Clinical Significance
Pleural tuberculosis often presents as an exudative pleural effusion where traditional Acid-Fast Bacilli (AFB) smear microscopy has very low sensitivity due to the paucibacillary nature (low bacterial load) of the fluid.

Speed and Sensitivity: CBNAAT bridges this gap by amplifying DNA, offering a much higher sensitivity than routine microscopy and delivering results within a few hours (compared to weeks for mycobacterial culture).

NTM Differentiation: Distinguishing between M.Tb and NTM is critical, as the clinical management and antibiotic regimens for NTM infections differ significantly from standard tuberculosis treatment.

Drug Resistance Screening: Early identification of Rifampicin resistance serves as a crucial surrogate marker for multidrug-resistant TB (MDR-TB), allowing clinicians to tailor effective treatment regimens immediately.

An AFB-M.Tb Detection (M.Tb/NTM Detection) by CBNAAT on BAL (Bronchoalveolar Lavage) fluid is an advanced, rapid molecular test used to diagnose complex lung infections.

This test simultaneously looks for classic Tuberculosis (M.Tb) and Non-Tuberculous Mycobacteria (NTM). It is specifically performed on fluid collected directly from the deep airways of the lungs during a bronchoscopy procedure.

1. Understanding the Terms
BAL (Bronchoalveolar Lavage): A procedure where a small scope is passed into the lungs and a sterile saline solution is used to flush out and collect cells and secretions from the deep airways. This is often done when a patient cannot produce regular sputum or when previous sputum tests were inconclusive.

M.Tb: Mycobacterium tuberculosis, the bacteria responsible for classic, contagious pulmonary TB.

NTM: Non-Tuberculous Mycobacteria. These are environmental bacteria that can cause lung disease mimicking TB, but they are generally non-contagious and require a completely different combination of antibiotics.

CBNAAT: Cartridge-Based Nucleic Acid Amplification Test. An automated PCR system that multiplies and detects the unique DNA sequences of these bacteria within 2 hours.

2. Why BAL Fluid is Used
BAL fluid is highly valuable for diagnosing tough respiratory cases:

Deep Lung Access: It captures samples directly from the lower respiratory tract, where the infection is actively residing.

Overcoming Low Bacterial Counts: Traditional microscope smears require a high concentration of bacteria to show a positive result. Because CBNAAT is highly sensitive and multiplies DNA, running it on BAL fluid catches early-stage or hidden infections that standard sputum tests miss.

An AFB-M.Tb Detection (M.Tb/NTM Detection) by CBNAAT on Ascitic Fluid is a targeted molecular diagnostic test designed to identify tuberculosis infections within the peritoneal (abdominal) cavity.

This specific test is a frontline tool for diagnosing Tuberculous Peritonitis (abdominal TB). What makes this panel unique is its dual capability: it not only checks for the classic Mycobacterium tuberculosis complex but also differentiates it from NTM (Non-Tuberculous Mycobacteria), which require completely different clinical treatment strategies.

1. Breaking Down the Terminology
M.Tb: Mycobacterium tuberculosis, the primary pathogen responsible for classic tuberculosis.

NTM: Non-Tuberculous Mycobacteria (also known as atypical mycobacteria). These are environmental organisms that can mimic TB symptoms and presentation but do not respond to standard anti-TB medications.

CBNAAT: Cartridge-Based Nucleic Acid Amplification Test. It uses automated, rapid Polymerase Chain Reaction (PCR) technology to detect the specific DNA signatures of these organisms.

Ascitic Fluid: The fluid that builds up in the peritoneal cavity of the abdomen (a condition called ascites) due to inflammation, infection, or other medical conditions.

An AFB-Xpert Panel (M.Tb Detection & Rifampicin Resistance) by CBNAAT for pulmonary samples is a highly efficient, automated molecular test. It serves as the frontline tool for rapidly diagnosing Tuberculosis (TB) in the lungs and checking if the bacteria are resistant to one of the most powerful first-line TB medications, Rifampicin.

Unlike extra-pulmonary testing, which deals with fluids and tissues from other organs, pulmonary testing specifically evaluates secretions from the respiratory tract.

1. What does the name mean?
AFB: Acid-Fast Bacilli (the class of bacteria to which Mycobacterium tuberculosis belongs).

CBNAAT: Cartridge-Based Nucleic Acid Amplification Test (commonly known as the GeneXpert test). It uses PCR technology to multiply and detect the DNA of the TB bacteria.

Pulmonary samples: Samples originating from the lungs and respiratory airways.

2. Common Pulmonary Sample Types
Because pulmonary TB directly affects the lungs, the sample types are respiratory secretions:

Sputum (Spontaneous): The thick mucus coughed up deeply from the lungs. This is the most common sample type.

Induced Sputum: If a patient cannot cough up sputum naturally, they inhale a sterile saline mist to help loosen secretions.

Bronchoalveolar Lavage (BAL): Fluid collected during a bronchoscopy, where a doctor passes a small scope into the lungs and flushes the area with saline. This is often used for complex or hard-to-diagnose cases.

Gastric Aspirate/Lavage: Commonly used in young children who cannot expectorate (spit out) sputum and instead swallow their respiratory secretions overnight.

An AFB-Xpert Panel (M.Tb Detection & Rifampicin Resistance) by CBNAAT for extra-pulmonary samples is a rapid molecular test used to detect Mycobacterium tuberculosis (the bacteria that causes TB) and check if it is resistant to Rifampicin, a core first-line TB medication.

When performed on extra-pulmonary samples (tissue or fluid from outside the lungs), it is a crucial tool for diagnosing complex, hard-to-reach TB infections.

1. What does the name mean?
AFB: Acid-Fast Bacilli (the family of bacteria Mycobacterium tuberculosis belongs to).

CBNAAT: Cartridge-Based Nucleic Acid Amplification Test. It is a fully automated PCR (polymerase chain reaction) test that looks for the DNA of the bacteria.

Extra-pulmonary samples: Samples taken from body parts other than the lungs.

2. Common Sample Types Used
Because extra-pulmonary TB can affect almost any organ, the test can be run on various non-sputum samples, including:

Fluids: Pleural fluid (lung lining), cerebrospinal fluid (CSF for TB meningitis), ascitic fluid (abdomen), or synovial fluid (joints).

Tissue: Lymph node aspirates (FNAC) or biopsy tissue from suspected organs.

Urine: Used in suspected urogenital TB.

3. What the Test Detects
The test provides two critical pieces of information simultaneously, usually within 2 hours:

M.Tb Detection (Positive/Negative): Confirms whether Mycobacterium tuberculosis DNA is present in the sample.

Rifampicin (Rif) Resistance (Detected/Not Detected): It targets the rpoB gene of the bacteria. If mutations are found in this gene, it indicates the strain is resistant to Rifampicin. Because Rifampicin resistance is highly correlated with multi-drug resistant TB (MDR-TB), this serves as a critical early warning.

An AFB-DNA (TB-PCR) Detection by Real-Time PCR with Reflex to Rifampicin Resistance by Ultra CBNAAT on Tissue is an advanced molecular test specifically designed to diagnose Histopathological or Extrapulmonary Tuberculosis (EPTB) within solid organ systems and structural tissues.

When tuberculosis manifests outside the lungs, it frequently forms deep-seated lesions or granulomas. Because the concentration of live bacteria in these dense tissues is often incredibly low (paucibacillary), traditional microscope smears and standard biopsy stains can easily miss them. This panel extracts the genetic blueprint (DNA) directly from tissue cells to deliver an incredibly rapid, ultra-sensitive diagnostic answer.

What Types of Tissue Specimens Are Evaluated?
This panel is performed on solid tissue biopsy specimens collected via needle aspiration, core biopsy, or surgical excision, including:

Lymph Nodes: Most commonly from cervical (neck), axillary, or mediastinal lymph nodes to diagnose TB Lymphadenitis.

Bone and Joint Tissue: Collected from suspected skeletal structures to identify bone TB or Pott’s Disease (spinal tuberculosis).

Gastrointestinal / Peritoneal Tissue: Biopsies taken from the bowel wall lining or omentum during an endoscopy or laparoscopy.

Pleural / Pericardial Tissue: Small structural samples taken from the protective sacs around the lungs or heart.

Skin / Soft Tissue: From non-healing chronic ulcers, nodules, or deep abscesses.

An AFB-DNA (TB-PCR) Detection by Real-Time PCR with Reflex to Rifampicin Resistance by Ultra CBNAAT on Sputum is a premier, ultra-sensitive molecular test for diagnosing Pulmonary Tuberculosis (TB).

While traditional microscopic smears look for the physical bacterium under a lens, this advanced panel directly extracts and copies the genetic blueprint (DNA) of the Mycobacterium tuberculosis complex. It stands as a vital frontline diagnostic tool because it rapidly answers two clinical questions directly from a sputum sample: Is the patient infected with TB? and if so, Will standard first-line antibiotics work against it?

Deconstructing the Test Terminology
AFB-DNA (TB-PCR) by RTPCR: The laboratory uses Real-Time Polymerase Chain Reaction to replicate specific genetic sequences unique to TB. Because it amplifies target DNA millions of times, it can detect the presence of the bacteria even if the patient has a very low bacterial load (paucibacillary sputum), which a standard microscope smear would completely miss.

Reflex to Ultra CBNAAT: "Reflexing" means the laboratory automation software automatically launches a secondary, deeper test only if the initial PCR screen detects TB DNA. The patient does not need to return to give a second sample.

Ultra CBNAAT (Cartridge-Based Nucleic Acid Amplification Test): This refers specifically to the newer GeneXpert MTB/RIF Ultra technology. The "Ultra" cartridge features an increased sample chamber volume and nested PCR technology, providing unmatched sensitivity.

Rifampicin Resistance: Rifampicin is a cornerstone drug in standard anti-tubercular therapy. The Ultra assay maps the bacterial rpoB gene to check for mutations that make the bacteria immune to Rifampicin. Resistance to this drug is a critical marker for Multidrug-Resistant Tuberculosis (MDR-TB).

An AFB-DNA (TB-PCR) Detection by Real-Time PCR with Reflex to Rifampicin Resistance by Ultra CBNAAT on Body Fluids is a specialized, rapid molecular diagnostic profile. It is specifically designed to diagnose Extrapulmonary Tuberculosis (EPTB)—tuberculosis that has developed outside of the lungs in various fluid-filled compartments of the body.

Because tuberculosis bacteria are notoriously difficult to find under a microscope in liquid body samples (paucibacillary samples), this DNA-amplification test provides an essential, highly sensitive diagnostic solution.

What Types of Body Fluids Are Tested?
This panel can be performed on several types of clinically harvested fluids, depending on where the infection is suspected:

Cerebrospinal Fluid (CSF): Taken via a lumbar puncture to diagnose life-threatening TB Meningitis (infection of the membranes surrounding the brain and spinal cord).

Pleural Fluid: Drawn from the space surrounding the lungs to diagnose TB Pleurisy.

Ascitic / Peritoneal Fluid: Collected from the abdominal cavity to diagnose Peritoneal TB (gastrointestinal tuberculosis).

Synovial Fluid: Extracted from a swollen joint space to evaluate TB Arthritis or musculoskeletal tuberculosis.

Pericardial Fluid: Harvested from the sac surrounding the heart to diagnose TB Pericarditis.

Unlike a basic microscopic visual smear, this test directly targets and amplifies the genetic code (DNA) of the Mycobacterium tuberculosis (MTB) bacteria. It is widely considered a frontline diagnostic powerhouse because it answers two vital clinical questions rapidly: Is TB DNA present? and if so, Is it a drug-resistant strain?

Deconstructing the Complex Test NameAFB-DNA (TB-PCR) by RTPCR:

This is the first line of the test. The laboratory uses Real-Time Polymerase Chain Reaction (RTPCR) to locate even tiny, fragmented copies of tuberculosis DNA in a sample. It is far more sensitive than a microscope smear and can detect bacteria even in very low concentrations (paucibacillary infections). Reflex to Ultra CBNAAT: "Reflex" means the laboratory computer automatically triggers a secondary, deeper test only if the first step comes back positive. Ultra CBNAAT (Cartridge Based Nucleic Acid Amplification Test): This refers specifically to the GeneXpert MTB/RIF Ultra technology. It is a highly advanced molecular cartridge system that acts as a confirmation step and maps the bacterial genome to look for drug mutations. Rifampicin Resistance: Rifampicin is one of the foundational, most powerful first-line antibiotics used to cure TB. Resistance to Rifampicin is a primary medical warning indicator for MDR-TB (Multidrug-Resistant Tuberculosis), meaning standard TB medications will not work and a specialized treatment path is required.